Evidence map›Paper›PMID 31426355›Full record

ArticleCells2019

Myeloid Krüppel-Like Factor 2 Critically Regulates K/BxN Serum-Induced Arthritis.

Manjusri Das, Moonmoon Deb, Dipranjan Laha, Matthew Joseph, Suman Kanji, Reeva Aggarwal, O Hans Iwenofu, Vincent J Pompili, Wael Jarjour, Hiranmoy Das

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. KLF transcription factors in bone diseases.Journal of cellular and molecular medicine · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Manjusri DasDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH 43210, USA.
Moonmoon DebDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Dipranjan LahaDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Matthew JosephDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH 43210, USA.
Suman KanjiDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Reeva AggarwalDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH 43210, USA.
O Hans IwenofuDepartment of Pathology, College of Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH 43210, USA.
Vincent J PompiliDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH 43210, USA.
Wael JarjourDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH 43210, USA.
Hiranmoy DasDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH 43210, USA. hiranmoy.das@ttuhsc.edu.ORCID 0000-0002-3343-0096
The Ohio State University Wexner Medical Center · USTexas Tech University · US

Funding

Myeloid KLF2 regulation mechanisms in rheumatoid arthritisR01AR068279 · NIAMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI DAS, HIRANMOY · 2016 to 2022
$1.7M
Corneal Endothelial Stem Cells for Treatment of Corneal Endothelial DystrophiesR41EY024217 · NEI · RASHMIVU, LLC · PI DAS, HIRANMOY · 2014 to 2016
$268k
Nanofiber Expanded CD34+ Stem Cells for Osteoporosis TherapyR41AG057242 · NIA · HNB THERAPEUTICS, LLC · PI DAS, HIRANMOY · 2018 to 2018
$225k
NEI NIH HHS R41 EY024217NIAMS NIH HHS R01 AR068279NIA NIH HHS R41 AG057242
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an immune-mediated inflammatory disease, and Krüppel-like factor 2 (KLF2) regulates immune cell activation and function. Herein, we show that in our experiments 50% global deficiency of KLF2 significantly elevated arthritic inflammation and pathogenesis, osteoclastic differentiation, matrix metalloproteinases (MMPs), and inflammatory cytokines in K/BxN serum-induced mice. The severities of RA pathogenesis, as well as the causative and resultant cellular and molecular factors, were further confirmed in monocyte-specific KLF2 deficient mice. In addition, induction of RA resulted in a decreased level of KLF2 in monocytes isolated from both mice and humans along with higher migration of activated monocytes to the RA sites in humans. Mechanistically, overexpression of KLF2 decreased the level of MMP9; conversely, knockdown of KLF2 increased MMP9 in monocytes along with enrichment of active histone marks and histone acetyltransferases on the MMP9 promoter region. These findings define the critical regulatory role of myeloid KLF2 in RA pathogenesis.

Indexed as

AnimalsArthritis, ExperimentalArthritis, RheumatoidCell DifferentiationCells, CulturedCytokinesHumansInflammationKruppel-Like Transcription FactorsMatrix Metalloproteinase 9MiceMice, Inbred C57BLMice, KnockoutMonocytesOsteoclastsCytokinesKLF2 protein, humanKlf2 protein, mouseKruppel-Like Transcription FactorsMatrix Metalloproteinase 9MMP9 protein, humanconditional knockout miceinflammationKLF2MMP9monocytesosteoclastsrheumatoid arthritis

Identifiers

PMID31426355
PMCPMC6721677
OpenAlexW2967195651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.